Erratum: Prognosis and outcomes of lymphocyte-predominant Hodgkin's lymphoma

被引：0
|
作者：
Grace Suh
Anas Younes
机构：
来源：
Nature Clinical Practice Oncology | 2008年 / 5卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Nature Clinical Practice Oncology (2008) 5: 368–369 [doi:10.1038/ncponc1153]
引用
收藏
页码：493 / 493
相关论文
共 50 条
  • [21] Conventional cytogenetics of nodular lymphocyte-predominant Hodgkin's lymphoma
    A Stamatoullas
    J-M Picquenot
    C Dumesnil
    P Ruminy
    D Penther
    P Bertrand
    M-N Courel
    C Maisonneuve
    A François
    P Gaulard
    H Tilly
    C Bastard
    Leukemia, 2007, 21 : 2064 - 2067
  • [22] Rituximab monotherapy in relapsed lymphocyte-predominant Hodgkin's lymphoma
    Galan, Laura
    Sanchez, Antonio C.
    Cantos, Blanca
    Provencio, Mariano
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2010, 12 (05): : 384 - 386
  • [23] Conventional cytogenetics of nodular lymphocyte-predominant Hodgkin's lymphoma
    Stamatoullas, A.
    Picquenot, J-M
    Dumesnil, C.
    Ruminy, P.
    Penther, D.
    Bertrand, P.
    Courel, M-N
    Maisonneuve, C.
    Francois, A.
    Gaulard, P.
    Tilly, H.
    Bastard, C.
    LEUKEMIA, 2007, 21 (09) : 2064 - 2067
  • [24] Pathogenesis of Classical and Lymphocyte-Predominant Hodgkin Lymphoma
    Schmitz, Roland
    Stanelle, Jens
    Hansmann, Martin-Leo
    Kueppers, Ralf
    ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2009, 4 : 151 - 174
  • [25] Management of nodular lymphocyte-predominant Hodgkin lymphoma
    Eichenauer, Dennis A.
    Engert, Andreas
    HEMATOLOGICAL ONCOLOGY, 2013, 31 : 47 - 50
  • [26] Treatment of nodular lymphocyte-predominant Hodgkin lymphoma
    Eichenauer, Dennis A.
    Eich, Hans Theodor
    Engert, Andreas
    ONKOLOGIE, 2022, 28 (10): : 908 - 913
  • [27] Nodular lymphocyte-predominant Hodgkin's lymphoma: Principles of diagnosis and treatment
    Moiseeva, T. N.
    Al-Radi, L. S.
    Kovrigina, A. M.
    Goryacheva, S. R.
    Julakyan, U. L.
    Margolin, O. V.
    Skidan, N. I.
    Tseytlina, M. A.
    Kravchenko, S. K.
    TERAPEVTICHESKII ARKHIV, 2015, 87 (11): : 78 - 83
  • [28] What Is the Appropriate Systemic Chemotherapy for Lymphocyte-Predominant Hodgkin's Lymphoma?
    Mauch, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) : E8 - E8
  • [29] ANALYSIS OF PATIENTS DIAGNOSED OF NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN'S LYMPHOMA
    Pilar, A.
    Fernandez, R.
    Solano, J.
    Alonso Nogues, E.
    Zanabilli, Y.
    Alonso, J. M.
    Payer, A. R.
    Vicente, J. M.
    Medina, J.
    Taboada, F.
    Vargas, M.
    Alarcon, C.
    Moran, M.
    Gonzalez-Ordonez, A.
    Palicio, M. A.
    Ortiz, S.
    Chamorro, C.
    HAEMATOLOGICA, 2014, 99 : 680 - 681
  • [30] Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma
    Borchmann, Sven
    Joffe, Erel
    Moskowitz, Craig H.
    Zelenetz, Andrew D.
    Noy, Ariela
    Portlock, Carol S.
    Gerecitano, John F.
    Batlevi, Connie L.
    Caron, Philip C.
    Drullinsky, Pamela
    Hamilton, Audrey
    Hamlin, Paul A., Jr.
    Horwitz, Steven M.
    Kumar, Anita
    Matasar, Matthew J.
    Moskowitz, Alison J.
    Owens, Colette N.
    Palomba, M. Lia
    Younes, Anas
    Straus, David J.
    BLOOD, 2019, 133 (20) : 2121 - 2129
12345